Prevalence of Venous Thromboembolic Events and Diagnostic Performance of the Wells Score and Revised Geneva Scores for Pulmonary Embolism in Patients with Interstitial Lung Disease: A Prospective Study

被引:23
作者
Luo, Qun [1 ]
Xie, Jiaxing [1 ]
Han, Qian [1 ]
Tang, Chunli [1 ]
Chen, Xiaobo [1 ]
Wu, Lulu [1 ]
Chen, Rongchang [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
关键词
Venous thromboembolism; Interstitial lung disease; Pulmonary embolism; Wells score; Revised Geneva scores; CLASSIFICATION CRITERIA; RISK; FIBROSIS;
D O I
10.1016/j.hlc.2014.02.014
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background To determine the prevalence of venous thromboembolism (VTE) in patients with connective tissue disease-related interstitial lung diseases (CTD-ILD) and idiopathic interstitial pneumonia (TIP) and to further evaluate associated risk factors. To also examine the diagnostic performance of the Wells score and the revised Geneva scores for diagnosing pulmonary embolism (PE) in ILD patients. Method Fifty-seven patients with CTD-ILD and TIP were prospectively enrolled. Plasma D-dimer was measured by ELISA. Deep-vein thrombosis (DVT) was examined by venous ultrasonography and PE by computed tomography pulmonary angiography. PE prevalence was further assessed by the Wells score and the revised Geneva score. Results VTE was diagnosed in 15 (26.3%, 15/57) patients. Bivariate analysis revealed that dyspnoea (OR 3.750, 95% CI 1.095-12.842, P=0.035), lower extremity oedema (OR 8.667, 95%CI1.814-41.408, P=0.007), palpitations (OR 4.75, 95%CI1.073-21.032, P=0.040), and positive D-dimer (OR 5.087, 95%CI 1.015-25.485, P=0.048) were associated with VTE. Using the Wells Score, 46 (80.70%), eight (14.4%) and three (5.26%) patients had a low, intermediate and high probability of PE, respectively, with seven (15.22%), three (37.5%) and two (66.67%) of the respective cases confirmed. By the revised Geneva score, 23 (40.35%), 32 (56.14%) and two (3.51%) patients had a low, intermediate and high probability of PE, respectively, with two (8.70%), nine (28.13%) and one (50.00%) of the respective cases confirmed. The AUC for the Wells score and the revised Geneva score was 0.720 +/- 0.083 (CI 0.586 to 0.831) and 0.704 +/- 0.081 (CI 0.568 to 0.817), respectively. Conclusion VTE can be seen in approximately one fourth of patients with CTD-ILD or TIP and the Wells spore and the revised Geneva score can be used for categorising PE risk.
引用
收藏
页码:778 / 785
页数:8
相关论文
共 30 条
[1]
Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646
[2]
Interstitial Lung Disease in the Connective Tissue Diseases [J].
Antin-Ozerkis, Danielle ;
Rubinowitz, Ami ;
Evans, Janine ;
Homer, Robert J. ;
Matthay, Richard A. .
CLINICS IN CHEST MEDICINE, 2012, 33 (01) :123-+
[3]
Bhambhani M, 1996, J Assoc Physicians India, V44, P89
[4]
POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[5]
Cavaco Raquel A, 2009, Cases J, V2, P9156, DOI 10.1186/1757-1626-2-9156
[6]
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study [J].
Choi, Hyon K. ;
Rho, Young-Hee ;
Zhu, Yanyan ;
Cea-Soriano, Lucia ;
Avina-Zubieta, Juan Antonio ;
Zhang, Yuqing .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (07) :1182-1187
[7]
Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality [J].
Cohen, Alexander T. ;
Agnelli, Giancarlo ;
Anderson, Frederick A. ;
Arcelus, Juan I. ;
Bergqvist, David ;
Brecht, Josef G. ;
Greer, Ian A. ;
Heit, John A. ;
Hutchinson, Julia L. ;
Kakkar, Ajay K. ;
Mottier, Dominique ;
Oger, Emmanuel ;
Samama, Meyer-Michel ;
Spannagl, Michael .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (04) :756-764
[8]
DORIA A, 1992, J RHEUMATOL, V19, P259
[9]
IDIOPATHIC PULMONARY FIBROSIS - ANOTHER CAUSE OF VENTILATION PERFUSION MISMATCH [J].
EARY, JF ;
FISHER, MC ;
CERQUEIRA, MD .
CLINICAL NUCLEAR MEDICINE, 1986, 11 (06) :396-399
[10]
European Respiratory Society, 2002, Am J Respir Crit Care Med, V165, P277, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]